BWAY logo

BrainsWay Ltd.TASE:BWAY Stock Report

Market Cap ₪772.2m
Share Price
₪20.43
My Fair Value
AN
AnalystConsensusTarget
₪28
25.9% undervalued intrinsic discount
1Y44.9%
7D0.4%
Portfolio Value
View

BrainsWay Ltd.

TASE:BWAY Stock Report

Market Cap: ₪772.2m

BrainsWay (BWAY) Stock Overview

Develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. More details

BWAY fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

BWAY Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

BrainsWay Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BrainsWay
Historical stock prices
Current Share Price₪20.43
52 Week High₪23.59
52 Week Low₪11.59
Beta0.32
1 Month Change-11.25%
3 Month Change23.82%
1 Year Change44.89%
3 Year Change103.49%
5 Year Change97.39%
Change since IPO32.46%

Recent News & Updates

Investors Will Want BrainsWay's (TLV:BWAY) Growth In ROCE To Persist

Jun 29
Investors Will Want BrainsWay's (TLV:BWAY) Growth In ROCE To Persist

After Leaping 25% BrainsWay Ltd. (TLV:BWAY) Shares Are Not Flying Under The Radar

May 21
After Leaping 25% BrainsWay Ltd. (TLV:BWAY) Shares Are Not Flying Under The Radar

Recent updates

Investors Will Want BrainsWay's (TLV:BWAY) Growth In ROCE To Persist

Jun 29
Investors Will Want BrainsWay's (TLV:BWAY) Growth In ROCE To Persist

After Leaping 25% BrainsWay Ltd. (TLV:BWAY) Shares Are Not Flying Under The Radar

May 21
After Leaping 25% BrainsWay Ltd. (TLV:BWAY) Shares Are Not Flying Under The Radar

After Leaping 27% BrainsWay Ltd. (TLV:BWAY) Shares Are Not Flying Under The Radar

Aug 23
After Leaping 27% BrainsWay Ltd. (TLV:BWAY) Shares Are Not Flying Under The Radar

We Think BrainsWay (TLV:BWAY) Can Easily Afford To Drive Business Growth

May 03
We Think BrainsWay (TLV:BWAY) Can Easily Afford To Drive Business Growth

BrainsWay Ltd.'s (TLV:BWAY) P/S Is Still On The Mark Following 26% Share Price Bounce

Dec 25
BrainsWay Ltd.'s (TLV:BWAY) P/S Is Still On The Mark Following 26% Share Price Bounce

We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

Dec 21
We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

Sep 19
We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

We're Keeping An Eye On BrainsWay's (TLV:BWAY) Cash Burn Rate

Jun 01
We're Keeping An Eye On BrainsWay's (TLV:BWAY) Cash Burn Rate

We Think BrainsWay (TLV:BWAY) Can Afford To Drive Business Growth

Aug 15
We Think BrainsWay (TLV:BWAY) Can Afford To Drive Business Growth

BrainsWay (TLV:BWAY) Is In A Good Position To Deliver On Growth Plans

May 13
BrainsWay (TLV:BWAY) Is In A Good Position To Deliver On Growth Plans

BrainsWay (TLV:BWAY) Is In A Strong Position To Grow Its Business

Jan 31
BrainsWay (TLV:BWAY) Is In A Strong Position To Grow Its Business

What Is The Ownership Structure Like For Brainsway Ltd. (TLV:BWAY)?

Mar 02
What Is The Ownership Structure Like For Brainsway Ltd. (TLV:BWAY)?

Shareholder Returns

BWAYIL Medical EquipmentIL Market
7D0.4%2.1%-0.5%
1Y44.9%36.6%64.7%

Return vs Industry: BWAY exceeded the IL Medical Equipment industry which returned 33% over the past year.

Return vs Market: BWAY underperformed the IL Market which returned 64% over the past year.

Price Volatility

Is BWAY's price volatile compared to industry and market?
BWAY volatility
BWAY Average Weekly Movement6.4%
Medical Equipment Industry Average Movement6.3%
Market Average Movement5.0%
10% most volatile stocks in IL Market8.4%
10% least volatile stocks in IL Market3.4%

Stable Share Price: BWAY's share price has been volatile over the past 3 months compared to the IL market.

Volatility Over Time: BWAY's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of IL stocks.

About the Company

FoundedEmployeesCEOWebsite
2003120Hadar Levywww.brainsway.com

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry.

BrainsWay Ltd. Fundamentals Summary

How do BrainsWay's earnings and revenue compare to its market cap?
BWAY fundamental statistics
Market cap₪772.18m
Earnings (TTM)₪13.18m
Revenue (TTM)₪146.23m
58.6x
P/E Ratio
5.3x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BWAY income statement (TTM)
RevenueUS$43.46m
Cost of RevenueUS$11.08m
Gross ProfitUS$32.38m
Other ExpensesUS$28.46m
EarningsUS$3.92m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.10
Gross Margin74.51%
Net Profit Margin9.01%
Debt/Equity Ratio0%

How did BWAY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/29 10:00
End of Day Share Price 2025/07/29 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BrainsWay Ltd. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuH.C. Wainwright & Co.
Jeffrey CohenLadenburg Thalmann & Company
Carl ByrnesNorthland Capital Markets